Members area 
Short Bowel Syndrome—Pre-Market Entry Study
Task:
To assess the opportunity of accessing the local market.
Task:
To assess the opportunity of accessing the local market.
Client:
EU-based Market Access consultancy.
Region:
Ukraine
Deliverables:
- Detailed report on the Short Bowel Syndrome in Ukraine.
- Regulatory environment overview.
- Pricing & Reimbursement status.
- Map of key stakeholders and decision-makers.
Product in focus:
Teduglutide brand—the first and only long-term therapy indicated for the treatment of patients with SBS-IF (orphan disease).
Key areas covered in the project:
- Analysis of the short bowel syndrome-intestinal failure (SBS-IF) market in the country.
- Assessment of the existing competitive environment in the core market.
- Identification of the total patients' population for the targeted indication.
- Estimation of time to achieve public funding.
- Overview of the public funding of medicines in Ukraine.
- Overview of the situation concerning the public funding of orphan drugs in the country.
- Mapping decision-makers in the area of demand forming for orphan drugs in Ukraine.
Project
leads
Eugene BROVKO
Partner, Pharma & MedTech Market Access
Download
our E-Brochure
